{"title":"沉默信号转导和转录激活因子3 (STAT3)和使用抗程序性细胞死亡配体1 (PD-L1)抗体诱导免疫反应和抗肿瘤活性。","authors":"Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi","doi":"10.12659/MSM.941845","DOIUrl":null,"url":null,"abstract":"<p><p>It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.</p>","PeriodicalId":18276,"journal":{"name":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research","volume":"29 ","pages":"e941845"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/88/medscimonit-29-e941845.PMC10368140.pdf","citationCount":"0","resultStr":"{\"title\":\"Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.\",\"authors\":\"Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi\",\"doi\":\"10.12659/MSM.941845\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.</p>\",\"PeriodicalId\":18276,\"journal\":{\"name\":\"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research\",\"volume\":\"29 \",\"pages\":\"e941845\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/88/medscimonit-29-e941845.PMC10368140.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12659/MSM.941845\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12659/MSM.941845","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.
It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.